Molecular neurobiology of addiction: What's all the (Δ)FosB about?

American Journal of Drug and Alcohol Abuse

Volumn 40, Issue 6, 2014, Pages 428-437

  Ruffle, James K ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Addiction; Biomarker; DeltaFosB; Epigenetics; Transcription; Treatment

Indexed keywords

4 AMINOBUTYRIC ACID; CYCLIN DEPENDENT KINASE 5; DOPAMINE; I KAPPA B; RNA; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FOSB; FOSB PROTEIN, HUMAN; PROTEIN C FOS;

ADDICTION; ALTERNATIVE RNA SPLICING; BRAIN DEPTH STIMULATION; ELECTROACUPUNCTURE; GENE EXPRESSION; GENE FUNCTION; GENE INDUCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MOLECULAR PATHOLOGY; NEUROBIOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PROCESSING; REVIEW; UPREGULATION; ANIMAL; BRAIN; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; BEHAVIOR, ADDICTIVE; BRAIN; GENE EXPRESSION REGULATION; HUMANS; PROTO-ONCOGENE PROTEINS C-FOS; SUBSTANCE-RELATED DISORDERS; UP-REGULATION;

EID: 84911861022     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2014.933840     Document Type: Review

References (126)

1. American Psychiatric Association. DSM-5 Task Force. Diagnostic and statistical manual of mental disorders: DSM-5, 5th ed. Washington, DC: American Psychiatric Association; 2013.
2. Sabatinelli D, Bradley MM, Lang PJ, Costa VD, Versace F. Pleasure rather than salience activates human nucleus accumbens and medial prefrontal cortex. J Neurophysiol 2007;98:1374-1379.
3. Hope B, Kosofsky B, Hyman SE, Nestler EJ. Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. P Natl Acad Sci USA 1992; 89:5764-5768.
4. Schwienbacher I, Fendt M, Richardson R, Schnitzler HU. Temporary inactivation of the nucleus accumbens disrupts acquisition and expression of fear-potentiated startle in rats. Brain Res 2004;1027:87-93.
5. Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiat 2008;65: 220-231.
6. Couppis MH, Kennedy CH. The rewarding effect of aggression is reduced by nucleus accumbens dopamine receptor antagonism in mice. Psychopharmacology 2008;197:449-456.
7. Xia Y, Driscoll JR, Wilbrecht L, Margolis EB, Fields HL, Hjelmstad GO. Nucleus accumbens medium spiny neurons target non-dopaminergic neurons in the ventral tegmental area. J Neurosci 2011;31:7811-7816.
8. Werme M, Messer C, Olson L, Gilden L, Thoren P, Nestler EJ, Brene S. Delta FosB regulates wheel running. J Neurosci 2002;22: 8133-8138.
9. Berke JD, Hyman SE. Addiction, dopamine, and the molecular mechanisms of memory. Neuron 2000;25:515-532.
10. Graybiel AM, Moratalla R, Robertson HA. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci USA 1990;87:6912-6916.
11. Nakabeppu Y, Nathans D. A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity. Cell 1991;64: 751-759.
12. Young ST, Porrino LJ, Iadarola MJ. Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors. Proc Natl Acad Sci 1991;88:1291-1295.
13. Carlezon Jr WA, Thome J, Olson VG, Lane-Ladd SB, Brodkin ES, Hiroi N, Duman RS, et al. Regulation of cocaine reward by CREB. Science 1998;282:2272-2275.
14. Green TA, Alibhai IN, Unterberg S, Neve RL, Ghose S, Tamminga CA, Nestler EJ. Induction of activating transcription factors (ATFs) ATF2, ATF3, and ATF4 in the nucleus accumbens and their regulation of emotional behavior. J Neurosci 2008;28: 2025-2032.
15. Mackler SA, Korutla L, Cha XY, Koebbe MJ, Fournier KM, Bowers MS, Kalivas PW. NAC-1 is a brain POZ/BTB protein that can prevent cocaine-induced sensitization in the rat. J Neurosci 2000;20:6210-6217.
16. Green TA, Alibhai IN, Hommel JD, DiLeone RJ, Kumar A, Theobald DE, Neve RL, Nestler EJ. Induction of inducible cAMP early repressor expression in nucleus accumbens by stress or amphetamine increases behavioral responses to emotional stimuli. J Neurosci 2006;26:8235-8242.
17. O'Donovan KJ, Tourtellotte WG, Millbrandt J, Baraban JM. The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci 1999;22:167-173.
18. Dobrazanski P, Noguchi T, Kovary K, Rizzo CA, Lazo PS, Bravo R. Both products of the fosB gene, FosB and its short form, FosB/SF, are transcriptional activators in fibroblasts. Mol Cell Biol 1991; 11:5470-5478.
19. Morgan JI, Curran T. Immediate-early genes: ten years on. Trends Neurosci 1995;18:66-67.
20. Perez-Otano I, Mandelzys A, Morgan JI. MPTP-Parkinsonism is accompanied by persistent expression of a delta-FosB-like protein in dopaminergic pathways. Brain Res Mol Brain Res 1998;53: 41-52.
21. Chen J, Nye HE, Kelz MB, Hiroi N, Nakabeppu Y, Hope BT, Nestler EJ. Regulation of delta FosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments. Mol Pharmacol 1995;48:880-889.
22. Jorissen HJ, Ulery PG, Henry L, Gourneni S, Nestler EJ, Rudenko G. Dimerization and DNA-binding properties of the transcription factor DeltaFosB. Biochemistry 2007;46:8360-8372.
23. Carle TL, Ohnishi YN, Ohnishi YH, Alibhai IN, Wilkinson MB, Kumar A, Nestler EJ. Proteasome-dependent and-independent mechanisms for FosB destabilization: identification of FosB degron domains and implications for DeltaFosB stability. Eur J Neurosci 2007;25:3009-3019.
24. Marinescu V, Loomis PA, Ehmann S, Beales M, Potashkin JA. Regulation of retention of FosB intron 4 by PTB. PloS One 2007;2: e828.
25. Singh R, Valcarcel J, Green MR. Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science 1995;268:1173-1176.
26. Alibhai IN, Green TA, Potashkin JA, Nestler EJ. Regulation of fosB and DeltafosB mRNA expression: in vivo and in vitro studies. Brain Res 2007;1143:22-33.
27. Wagner EJ, Garcia-Blanco MA. Polypyrimidine tract binding protein antagonizes exon definition. Mol Cell Biol 2001;21: 3281-3288.
28. Lee DK, Oh JH, Shim YB, Choe ES. Protein kinase G regulates dopamine release, DeltaFosB expression, and locomotor activity after repeated cocaine administration: involvement of dopamine D2 receptors. Neurochem Res 2013;38:1424-1433.
29. Potashkin JA, Kang UJ, Loomis PA, Jodelka FM, Ding Y, Meredith GE. MPTP administration in mice changes the ratio of splice isoforms of fosB and rgs9. Brain Res 2007;1182:1-10.
30. Hope BT, Nye HE, Kelz MB, Self DW, Iadarola MJ, Nakabeppu Y, Duman RS, Nestler EJ. Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 1994;13:1235-1244.
31. Wisdom R, Yen J, Rashid D, Verma IM. Transformation by FosB requires a trans-activation domain missing in FosB2 that can be substituted by heterologous activation domains. Genes Dev 1992;6: 667-675.
32. Liu QR, Rubio FJ, Bossert JM, Marchant NJ, Fanous S, Hou X, Shaham Y, Hope BT. Detection of molecular alterations in methamphetamine-activated Fos-expressing neurons from a single rat dorsal striatum using fluorescence-activated cell sorting (FACS). J Neurochem 2014;128:173-185.
33. Ulery PG, Rudenko G, Nestler EJ. Regulation of DeltaFosB stability by phosphorylation. J Neurosci 2006;26:5131-5142.
34. Kelz MB, Nestler EJ. deltaFosB: a molecular switch underlying long-term neural plasticity. Curr Opin Neurol 2000;13:715-720.
35. Perrotti LI, Bolanos CA, Choi KH, Russo SJ, Edwards S, Ulery PG, Wallace DL, et al. DeltaFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment. Eur J Neurosci 2005;21:2817-2824.
36. Andersson M, Westin JE, Cenci MA. Time course of striatal DeltaFosB-like immunoreactivity and prodynorphin mRNA levels after discontinuation of chronic dopaminomimetic treatment. Eur J Neurosci 2003;17:661-666.
37. Zachariou V, Bolanos CA, Selley DE, Theobald D, Cassidy MP, Kelz MB, Shaw-Lutchman T, et al. An essential role for DeltaFosB in the nucleus accumbens in morphine action. Nat Neurosci 2006;9: 205-211.
38. McClung CA, Ulery PG, Perrotti LI, Zachariou V, Berton O, Nestler EJ. DeltaFosB: a molecular switch for long-term adaptation in the brain. Brain Res Mol Brain Res 2004;132:146-154.
39. Levine AA, Guan Z, Barco A, Xu S, Kandel ER, Schwartz JH. CREB-binding protein controls response to cocaine by acetylating histones at the fosB promoter in the mouse striatum. Proc Natl Acad Sci USA 2005;102:19186-19191.
40. Chen J, Kelz MB, Hope BT, Nakabeppu Y, Nestler EJ. Chronic Fos-related antigens: stable variants of deltaFosB induced in brain by chronic treatments. J Neurosci 1997;17:4933-4941.
41. Hiroi N, Brown JR, Haile CN, Ye H, Greenberg ME, Nestler EJ. FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects. Proc Natl Acad Sci USA 1997;94:10397-10402.
42. McDaid J, Dallimore JE, Mackie AR, Napier TC. Changes in accumbal and pallidal pCREB and deltaFosB in morphinesensitized rats: correlations with receptor-evoked electrophysiological measures in the ventral pallidum. Neuropsychopharmacol 2006;31:1212-1226.
43. McDaid J, Graham MP, Napier TC. Methamphetamine-induced sensitization differentially alters pCREB and DeltaFosB throughout the limbic circuit of the mammalian brain. Mol Pharmacol 2006;70: 2064-2074.
44. Nye HE, Hope BT, Kelz MB, Iadarola M, Nestler EJ. Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens. J Pharmacol Exp Ther 1995;275:1671-1680.
45. Ehrlich ME, Sommer J, Canas E, Unterwald EM. Periadolescent mice show enhanced DeltaFosB upregulation in response to cocaine and amphetamine. J Neurosci 2002;22:9155-9159.
46. Perrotti LI, Weaver RR, Robison B, Renthal W, Maze I, Yazdani S, Elmore RG, et al. Distinct patterns of DeltaFosB induction in brain by drugs of abuse. Synapse 2008;62:358-369.
47. Nye HE, Nestler EJ. Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol Pharmacol 1996;49: 636-645.
48. Hiroi N, Graybiel AM. Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum. J Comp Neurol 1996;374:70-83.
49. Pich EM, Pagliusi SR, Tessari M, Talabot-Ayer D, Hooft van Huijsduijnen R, Chiamulera C. Common neural substrates for the addictive properties of nicotine and cocaine. Science 1997;275: 83-86.
50. Kaplan GB, Leite-Morris KA, Fan W, Young AJ, Guy MD. Opiate sensitization induces FosB/DeltaFosB expression in prefrontal cortical, striatal and amygdala brain regions. PloS One 2011;6: e23574.
51. Perrotti LI, Hadeishi Y, Ulery PG, Barrot M, Monteggia L, Duman RS, Nestler EJ. Induction of deltaFosB in reward-related brain structures after chronic stress. J Neurosci 2004;24:10594-10602.
52. Gago B, Suarez-Boomgaard D, Fuxe K, Brene S, Reina-Sanchez MD, Rodriguez-Perez LM, Agnati LF, et al. Effect of acute and continuous morphine treatment on transcription factor expression in subregions of the rat caudate putamen. Marked modulation by D4 receptor activation. Brain Res 2011;1407:47-61.
53. Muller DL, Unterwald EM. D1 dopamine receptors modulate deltaFosB induction in rat striatum after intermittent morphine administration. J Pharmacol Exp Ther 2005;314:148-154.
54. Muschamp JW, Nemeth CL, Robison AJ, Nestler EJ, Carlezon Jr WA. DeltaFosB enhances the rewarding effects of cocaine while reducing the pro-depressive effects of the kappa-opioid receptor agonist U50488. Biol Psychiat 2012;71:44-50.
55. Atkins JB, Chlan-Fourney J, Nye HE, Hiroi N, Carlezon Jr WA, Nestler EJ. Region-specific induction of deltaFosB by repeated administration of typical versus atypical antipsychotic drugs. Synapse 1999;33:118-128.
56. Kaufling J, Waltisperger E, Bourdy R, Valera A, Veinante P, Freund-Mercier MJ, Barrot M. Pharmacological recruitment of the GABAergic tail of the ventral tegmental area by acute drug exposure. Brit J Pharmacol 2010;161:1677-1691.
57. Mombereau C, Lhuillier L, Kaupmann K, Cryan JF. GABAB receptor-positive modulation-induced blockade of the rewarding properties of nicotine is associated with a reduction in nucleus accumbens DeltaFosB accumulation. J Pharmacol Exp Ther 2007; 321:172-177.
58. Watanabe H, Henriksson R, Ohnishi YN, Ohnishi YH, Harper C, Sheedy D, Garrick T, et al. FOSB proteins in the orbitofrontal and dorsolateral prefrontal cortices of human alcoholics. Addict Biol 2009;14:294-297.
59. Colby CR, Whisler K, Steffen C, Nestler EJ, Self DW. Striatal cell type-specific overexpression of DeltaFosB enhances incentive for cocaine. J Neurosci 2003;23:2488-2493.
60. Lee KW, Kim Y, Kim AM, Helmin K, Nairn AC, Greengard P. Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens. Proc Natl Acad Sci USA 2006;103:3399-3404.
61. Chocyk A, Czyrak A, Wedzony K. Acute and repeated cocaine induces alterations in FosB/DeltaFosB expression in the paraventricular nucleus of the hypothalamus. Brain Res 2006;1090: 58-68.
62. Nunez C, Martin F, Foldes A, Luisa Laorden M, Kovacs KJ, Victoria Milanes M. Induction of FosB/DeltaFosB in the brain stress system-related structures during morphine dependence and withdrawal. J Neurochem 2010;114:475-487.
63. Garcia-Perez D, Laorden ML, Milanes MV, Nunez C. Glucocorticoids regulation of FosB/DeltaFosB expression induced by chronic opiate exposure in the brain stress system. PloS One 2012;7:e50264.
64. Van Waes V, Enache M, Berton O, Vinner E, Lhermitte M, Maccari S, Darnaudery M. Effect of prenatal stress on alcohol preference and sensitivity to chronic alcohol exposure in male rats. Psychopharmacol 2011;214:197-208.
65. Vialou V, Maze I, Renthal W, LaPlant QC, Watts EL, Mouzon E, Ghose S, et al. Serum response factor promotes resilience to chronic social stress through the induction of DeltaFosB. J Neurosci 2010;30:14585-14592.
66. Vialou V, Bagot RC, Cahill ME, Ferguson D, Robison AJ, Dietz DM, Fallon B, et al. Prefrontal cortical circuit for depressionand anxiety-related behaviors mediated by cholecystokinin: role of DeltaFosB. J Neurosci 2014;34:3878-3887.
67. Ortiz J, Fitzgerald LW, Lane S, Terwilliger R, Nestler EJ. Biochemical adaptations in the mesolimbic dopamine system in response to repeated stress. Neuropsychopharmacol 1996;14: 443-452.
68. Lobo MK, Zaman S, Damez-Werno DM, Koo JW, Bagot RC, DiNieri JA, Nugent A, et al. DeltaFosB induction in striatal medium spiny neuron subtypes in response to chronic pharmacological, emotional, and optogenetic stimuli. J Neurosci 2013;33: 18381-18395.
69. Berton O, Covington 3rd HE, Ebner K, Tsankova NM, Carle TL, Ulery P, Bhonsle A, et al. Induction of deltaFosB in the periaqueductal gray by stress promotes active coping responses. Neuron 2007;55:289-300.
70. Donahue RJ, Muschamp JW, Russo SJ, Nestler EJ, Carlezon Jr WA. Effects of striatal DeltaFosB overexpression and ketamine on social defeat stress-induced anhedonia in mice. Biol Psychol 2014; [epub ahead of print] doi: 10.1016/j.biopsych.2013.12.014.
71. Ohnishi YN, Ohnishi YH, Hokama M, Nomaru H, Yamazaki K, Tominaga Y, Sakumi K, et al. FosB is essential for the enhancement of stress tolerance and antagonizes locomotor sensitization by DeltaFosB. Biol Psychol 2011;70:487-495.
72. Vialou V, Robison AJ, Laplant QC, Covington 3rd HE, Dietz DM, Ohnishi YN, Mouzon E, et al. DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nat Neurosci 2010;13:745-752.
73. Kelz MB, Chen J, Carlezon Jr WA, Whisler K, Gilden L, Beckmann AM, Steffen C, et al. Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature 1999;401:272-276.
74. Kumar A, Choi KH, Renthal W, Tsankova NM, Theobald DE, Truong HT, Russo SJ, et al. Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 2005;48:303-314.
75. Renthal W, Kumar A, Xiao G, Wilkinson M, Covington 3rd HE, Maze I, Sikder D, et al. Genome-wide analysis of chromatin regulation by cocaine reveals a role for sirtuins. Neuron 2009;62:335-348.
76. Olausson P, Jentsch JD, Tronson N, Neve RL, Nestler EJ, Taylor JR. DeltaFosB in the nucleus accumbens regulates foodreinforced instrumental behavior and motivation. J Neurosci 2006; 26:9196-9204.
77. Wallace DL, Vialou V, Rios L, Carle-Florence TL, Chakravarty S, Kumar A, Graham DL, et al. The influence of DeltaFosB in the nucleus accumbens on natural reward-related behavior. J Neurosci 2008;28:10272-10277.
78. Van Bockstaele EJ, Gracy KN, Pickel VM. Dynorphin-immunoreactive neurons in the rat nucleus accumbens: ultrastructure and synaptic input from terminals containing substance P and/or dynorphin. J Comp Neurol 1995;351:117-133.
79. Pickel VM, Chan J, Sesack SR. Cellular substrates for interactions between dynorphin terminals and dopamine dendrites in rat ventral tegmental area and substantia nigra. Brain Res 1993;602:275-289.
80. Shippenberg TS, Rea W. Sensitization to the behavioral effects of cocaine: modulation by dynorphin and kappa-opioid receptor agonists. Pharmacol Biochem Be 1997;57:449-455.
81. Cenci MA. Transcription factors involved in the pathogenesis of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. Amino Acids 2002;23:105-109.
82. Zhu H, Lee M, Agatsuma S, Hiroi N. Pleiotropic impact of constitutive fosB inactivation on nicotine-induced behavioral alterations and stress-related traits in mice. Hum Mol Genet 2007; 16:820-836.
83. Hiroi N, Marek GJ, Brown JR, Ye H, Saudou F, Vaidya VA, Duman RS, et al. Essential role of the fosB gene in molecular, cellular, and behavioral actions of chronic electroconvulsive seizures. J Neurosci 1998;18:6952-6962.
84. Boundy VA, Chen J, Nestler EJ. Regulation of cAMP-dependent protein kinase subunit expression in CATH.a and SH-SY5Y cells. J Pharmacol Exp Ther 1998;286:1058-1065.
85. McClung CA, Nestler EJ. Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat Neurosci 2003;6: 1208-1215.
86. Winstanley CA, LaPlant Q, Theobald DE, Green TA, Bachtell RK, Perrotti LI, DiLeone RJ, et al. DeltaFosB induction in orbitofrontal cortex mediates tolerance to cocaine-induced cognitive dysfunction. J Neurosci 2007;27:10497-10507.
87. Bellone C, Luscher C. Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression. Nat Neurosci 2006;9:636-641.
88. Mameli M, Balland B, Lujan R, Luscher C. Rapid synthesis and synaptic insertion of GluR2 for mGluR-LTD in the ventral tegmental area. Science 2007;317:530-533.
89. White FJ, Hu XT, Zhang XF, Wolf ME. Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J Pharmacol Exp Ther 1995;273:445-454.
90. Mlewski EC, Krapacher FA, Ferreras S, Paglini G. Transient enhanced expression of Cdk5 activator p25 after acute and chronic d-amphetamine administration. Ann NY Acad Sci 2008;1139: 89-102.
91. Taylor JR, Lynch WJ, Sanchez H, Olausson P, Nestler EJ, Bibb JA. Inhibition of Cdk5 in the nucleus accumbens enhances the locomotor-activating and incentive-motivational effects of cocaine. Proc Natl Acad Sci USA 2007;104:4147-4152.
92. Peakman MC, Colby C, Perrotti LI, Tekumalla P, Carle T, Ulery P, Chao J, et al. Inducible, brain region-specific expression of a dominant negative mutant of c-Jun in transgenic mice decreases sensitivity to cocaine. Brain Res 2003;970: 73-86.
93. Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, Snyder GL, Yan Z, et al. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 2001;410:376-380.
94. Chen J, Zhang Y, Kelz MB, Steffen C, Ang ES, Zeng L, Nestler EJ. Induction of cyclin-dependent kinase 5 in the hippocampus by chronic electroconvulsive seizures: role of [Delta]FosB. J Neurosci 2000;20:8965-8971.
95. Norrholm SD, Bibb JA, Nestler EJ, Ouimet CC, Taylor JR, Greengard P. Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclindependent kinase-5. Neuroscience 2003;116:19-22.
96. Robinson TE, Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 2004;47:33-46.
97. Dumitriu D, Laplant Q, Grossman YS, Dias C, Janssen WG, Russo SJ, Morrison JH, Nestler EJ. Subregional, dendritic compartment, and spine subtype specificity in cocaine regulation of dendritic spines in the nucleus accumbens. J Neurosci 2012;32: 6957-6966.
98. Ferrer-Alcon M, La Harpe R, Guimon J, Garcia-Sevilla JA. Downregulation of neuronal cdk5/p35 in opioid addicts and opiate-treated rats: relation to neurofilament phosphorylation. Neuropsychopharmacol 2003;28:947-955.
99. Sasaki Y, Cheng C, Uchida Y, Nakajima O, Ohshima T, Yagi T, Taniguchi M, et al. Fyn and Cdk5 mediate semaphorin-3A signaling, which is involved in regulation of dendrite orientation in cerebral cortex. Neuron 2002;35:907-920.
100. Ang E, Chen J, Zagouras P, Magna H, Holland J, Schaeffer E, Nestler EJ. Induction of nuclear factor-kappaB in nucleus accumbens by chronic cocaine administration. J Neurochem 2001;79:221-224.
101. Asanuma M, Cadet JL. Methamphetamine-induced increase in striatal NF-kappaB DNA-binding activity is attenuated in superoxide dismutase transgenic mice. Brain Res Mol Brain Res 1998; 60:305-309.
102. Russo SJ, Wilkinson MB, Mazei-Robison MS, Dietz DM, Maze I, Krishnan V, Renthal W, et al. Nuclear factor kappa B signaling regulates neuronal morphology and cocaine reward. J Neurosci 2009;29:3529-3537.
103. Li Y, Zhang T, Douglas SD, Lai JP, Xiao WD, Pleasure DE, Ho WZ. Morphine enhances hepatitis C virus (HCV) replicon expression. Am J Pathol 2003;163:1167-1175.
104. Walton ME, Devlin JT, Rushworth MF. Interactions between decision making and performance monitoring within prefrontal cortex. Nat Neurosci 2004;7:1259-1265.
105. O'Doherty J, Kringelbach ML, Rolls ET, Hornak J, Andrews C. Abstract reward and punishment representations in the human orbitofrontal cortex. Nat Neurosci 2001;4:95-102.
106. Volz KG, Rubsamen R, von Cramon DY. Cortical regions activated by the subjective sense of perceptual coherence of environmental sounds: a proposal for a neuroscience of intuition. Cogn Affect Behav Neurosci 2008;8:318-328.
107. Winstanley CA, Green TA, Theobald DE, Renthal W, LaPlant Q, DiLeone RJ, Chakravarty S, Nestler EJ. DeltaFosB induction in orbitofrontal cortex potentiates locomotor sensitization despite attenuating the cognitive dysfunction caused by cocaine. Pharmacol Biochem Behav 2009;93:278-284.
108. Shaffer HJ, Eber GB. Temporal progression of cocaine dependence symptoms in the US National Comorbidity Survey. Addiction 2002;97:543-554.
109. Renthal W, Maze I, Krishnan V, Covington 3rd HE, Xiao G, Kumar A, Russo SJ, et al. Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron 2007;56:517-529.
110. Tsankova N, Renthal W, Kumar A, Nestler EJ. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 2007;8: 355-367.
111. Anier K, Malinovskaja K, Aonurm-Helm A, Zharkovsky A, Kalda A. DNA methylation regulates cocaine-induced behavioral sensitization in mice. Neuropsychopharmacol 2010;35: 2450-2461.
112. Renthal W, Carle TL, Maze I, Covington 3rd HE, Truong HT, Alibhai I, Kumar A, et al. Delta FosB mediates epigenetic desensitization of the c-fos gene after chronic amphetamine exposure. J Neurosci 2008;28:7344-7349.
113. Maze I, Covington 3rd HE, Dietz DM, LaPlant Q, Renthal W, Russo SJ, Mechanic M, et al. Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science 2010;327:213-216.
114. Deng JV, Rodriguiz RM, Hutchinson AN, Kim IH, Wetsel WC, West AE. MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants. Nat Neurosci 2010; 13:1128-1136.
115. Im HI, Hollander JA, Bali P, Kenny PJ. MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci 2010;13: 1120-1127.
116. Hollander JA, Im HI, Amelio AL, Kocerha J, Bali P, Lu Q, Willoughby D, et al. Striatal microRNA controls cocaine intake through CREB signalling. Nature 2010;466:197-202.
117. Theberge FR, Pickens CL, Goldart E, Fanous S, Hope BT, Liu QR, Shaham Y. Association of time-dependent changes in mu opioid receptor mRNA, but not BDNF, TrkB, or MeCP2 mRNA and protein expression in the rat nucleus accumbens with incubation of heroin craving. Psychopharmacology 2012;224: 559-571.
118. Liu HF, Zhou WH, Zhu HQ, Lai MJ, Chen WS. Microinjection of M(5) muscarinic receptor antisense oligonucleotide into VTA inhibits FosB expression in the NAc and the hippocampus of heroin sensitized rats. Neurosci Bull 2007;23:1-8.
119. Xiong M, Li J, Ye JH, Zhang C. Upregulation of DeltaFosB by propofol in rat nucleus accumbens. Anaesth Analg 2011;113: 259-264.
120. Kranioti EF, Mavroforou A, Mylonakis P, Michalodimitrakis M. Lethal self administration of propofol (Diprivan). A case report and review of the literature. Forensic Sci Int 2007;167: 56-58.
121. Guo L, Zhou H, Wang R, Xu J, Zhou W, Zhang F, Tang S, et al. DBS of nucleus accumbens on heroin seeking behaviors in self-administering rats. Drug Alcohol Depen 2013;129:70-81.
122. Li J, Sun Y, Ye JH. Electroacupuncture decreases excessive alcohol consumption involving reduction of FosB/DeltaFosB levels in reward-related brain regions. PloS One 2012;7:e40347.
123. Lhuillier L, Mombereau C, Cryan JF, Kaupmann K. GABA(B) receptor-positive modulation decreases selective molecular and behavioral effects of cocaine. Neuropsychopharmacol 2007;32: 388-398.
124. Velazquez-Sanchez C, Ferragud A, Renau-Piqueras J, Canales JJ. Therapeutic-like properties of a dopamine uptake inhibitor in animal models of amphetamine addiction. Int J Neuropsychoph 2011;14:655-665.
125. Radwanska K, Valjent E, Trzaskos J, Caboche J, Kaczmarek L. Regulation of cocaine-induced activator protein 1 transcription factors by the extracellular signal-regulated kinase pathway. Neuroscience 2006;137:253-264.
126. Ferguson D, Koo JW, Feng J, Heller E, Rabkin J, Heshmati M, Renthal W, et al. Essential role of SIRT1 signaling in the nucleus accumbens in cocaine and morphine action. J Neurosci 2013;33: 16088-16098.